Yorktown Management & Research Company’s Meridian Bioscience Inc VIVO Stock Holding History

Yorktown Management & Research Company’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-17,000	Closed	-$280K	–	528
2014 Q4	$280K	Sell	17,000 -7,000	-29%	-$120K	0.06%	198
2014 Q3	$425K	Hold	24,000	–	–	0.08%	121
2014 Q2	$495K	Buy	24,000 +7,000	+41%	+$144K	0.09%	120
2014 Q1	$370K	Sell	17,000 -7,000	-29%	-$160K	0.07%	139
2013 Q4	$637K	Hold	24,000	–	–	0.13%	108
2013 Q3	$568K	Buy	+24,000	New	+$560K	0.12%	113

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Yorktown Management & Research Company's VIVO Position: Q1 2015 in Review

Yorktown Management & Research Company sold out of Meridian Bioscience Inc (VIVO) in Q1 2015, closing a stake of 17,000 shares — an estimated $280K sold.

Yorktown Management & Research Company first reported a position in VIVO in Q3 2013 and held it in 6 quarters. The position peaked at $637K in Q4 2013. 159 funds tracked by Wall St. Rank hold VIVO as of Q1 2015.

Yorktown Management & Research Company reported no remaining Meridian Bioscience Inc position as of Q1 2015 after selling out during the quarter.
Yorktown Management & Research Company sold 17,000 Meridian Bioscience Inc shares in Q1 2015, an estimated $280K.
Yorktown Management & Research Company first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 6 quarters.
Yorktown Management & Research Company's Meridian Bioscience Inc position peaked at $637K in Q4 2013.
159 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2015.

Based on Yorktown Management & Research Company's 13F filing for Q1 2015, filed 23 Apr 2015.